The Latest in IT Security

How 23andMe tried to be the Google of spit


Last year, the U.S Food and Drug Administration (FDA) ordered DNA analysis service 23andMe to cease distribution of its test kits. Since then, the relationship between the two organizations has been an uneasy one. Over at New York Magazine, Lisa Miller explores 23andMes complex history and the epistemological dispute at the heart of its conflict with the FDA. It cares when a private company tells you that you have a gene that might kill you and sends you that tidbit in an email, which you can open alone, at night, without anyone near for comfort or consultation, Miller writes.

Comments are closed.


MONDAY, MAY 17, 2021

Mission-Critical Broadband – Why Governments Should Partner with Commercial Operators:
Many governments embrace mobile network operator (MNO) networks as ...

ARA at Scale: How to Choose a Solution That Grows With Your Needs:
Application release automation (ARA) tools enable best practices in...

The Multi-Model Database:
Part of the “new normal” where data and cloud applications are ...



Latest Comments